Cochlear Implant Atlas
CI Atlas · Beyond Hearing: The Implant for Tinnitus and the Balance System · Module 15

15One Device, Three Senses: The Road Ahead

The cochlear implant restored hearing. Then it was asked to quiet tinnitus. Now its descendants reach for balance. The horizon of this chapter is a single implanted platform that serves hearing, tinnitus, and the vestibular sense together — not three operations, but one. Getting there demands better electrodes, smarter motion sensing, closed-loop fitting, and trials that move the vestibular implant from the laboratory into the clinic, without leaving most of the world's patients behind.

FConvergence: one platform, three senses

The same surgical corridor and the same implant electronics that deliver sound to the cochlea can, in principle, also deliver tinnitus-masking stimulation and motion-encoded signals to the vestibular nerves. Combined cochleovestibular devices already restore hearing and balance from one implant body, proving the multi-sensory platform is buildable, not merely theoretical. Tinnitus suppression is a recognised benefit of cochlear stimulation, so a unified device could address hearing, tinnitus, and balance from shared hardware. The unifying idea is an implanted neural interface to the inner ear's sensory nerves, configured per patient for whichever combination of deficits they have.[2025][2009]

One implanted platform, three senses

InvestigationalEstablishedRoutinematurity on the same device →HearingTinnitusBalance
HearingRoutine

Restoring hearing is the device’s core, routine function with decades of evidence and standard-of-care status.

A single implanted platform can serve three senses, but each sits at a different point on the maturity scale. Hearing is routine standard-of-care; tinnitus relief is an established secondary benefit reported in many implanted ears; balance restoration is still investigational, shown only in small first-in-human series. Reading them on one axis makes clear how much further vestibular work has to travel before it joins hearing as routine care. Schematic.

TWhat must improve

Electrodes and current focusing must improve to limit current spread, so canal, otolith, and cochlear channels can be stimulated selectively without crosstalk or facial-nerve activation. Motion sensors and encoding algorithms must better translate real head movement into faithful, axis-aligned neural signals, closing the gap between partial and natural VOR. Closed-loop and self-fitting approaches — devices that sense the evoked response and adjust their own maps — would replace today's slow, manual, per-patient tuning. Surgical and electrode advances that reliably preserve cochlear hearing would let combined devices be offered to patients who still have residual hearing to protect.[2019][2017]

What must improve: impact vs readiness

priority zonereadiness →lowhighimpact →FocusingMotionSelf-fitTrials
Motion sensing & algorithmspriorityImpact9/10Readiness4/10

Reliable head-motion sensors and coding algorithms are essential to drive vestibular electrodes — the least mature, highest-stakes gap.

Four improvements stand between today’s pilots and routine multi-sense implants, scored on impact (how much each would matter) and readiness (how close it is). Motion sensing and algorithms and electrode focusing sit high-impact but low-readiness — the priority zone. Trials are nearer to hand, and closed-loop self-fitting is high-value but earliest-stage. The matrix is a way to triage where effort buys the most. Illustrative.

CFrom research to routine — honestly

Moving the vestibular implant from research to routine care requires larger, controlled, multicentre trials with longer follow-up than today's small series provide. Realistic timelines are measured in years, not months: stand-alone and combined vestibular devices remain investigational, and routine clinical availability is not imminent. An equity caveat applies sharply — if even basic cochlear implants reach only a fraction of those who need them worldwide, a costly multi-sensory implant risks widening the gap unless cost and access are designed in from the start. The honest promise is incremental: each generation should restore a little more function to a few more patients, not deliver a finished cure overnight.[2015][2021]

From research to routine — with an equity caveat

nowyears ahead →TodaySoonLaterYears out~5–15 patientsequity: access lags in lower-resource settings →
First-in-human series~5–15 patients

Combined and vestibular implants exist only as small investigational series — single-digit to low-double-digit patients at a few centres.

Today the evidence base for combined and vestibular implants is tiny — single-digit to low-double-digit patient series at a handful of centres. Expanded trials, regulatory approval, and finally routine care lie years down the road, in that order. Layered over the whole path is an equity caveat: even once a technology becomes routine in well-resourced systems, access typically lags for years in lower-resource settings. Progress in the lab does not automatically reach every patient. Schematic.

FClosing the chapter — and the threads it ties together

This chapter connects back to Emerging Technology: better electrodes, current focusing, and closed-loop fitting are the same advances that drive the next generation of all implantable inner-ear devices. It connects to the Balance chapter, where dizziness and bilateral vestibular loss were defined as the unmet need this technology targets. It connects to Bilateral & Bimodal hearing, which taught that two inputs serving complementary cues can outperform one — the same logic that motivates restoring multiple senses together. The takeaway: the cochlear implant began as a hearing device and is becoming a multi-sensory neural interface — a trajectory still unfolding, with both real patients helped and real distance left to travel.[2009][2025]

Case 30.15 · One Device, Three Senses
A patient asks her surgeon: "I've read about an implant that could fix my hearing, my ringing, and my balance all at once. When can I get it?" She has bilateral vestibular loss, profound hearing loss, and disabling tinnitus.

What is the most accurate and honest answer?

Self-assessment — Module 153 questions
Question 1

What is the unifying vision that closes this chapter?

Question 2

Which improvement would most directly let multi-sensory implants stimulate cochlear, canal, and otolith targets selectively?

Question 3

What equity caveat should temper enthusiasm for advanced multi-sensory implants?

Tracked locally in your browser — see /progress for the dashboard.